Sector valuations RaySearch Laboratories AB
Stocks
RAY B
SE0000135485
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 174.40 SEK | -2.79% |
|
-25.47% | -23.51% |
| 08:18am | Affarsvarlden issues a neutral recommendation for Raysearch after the profit warning | FW |
| 07-16 | RaySearch Laboratories AB Provides Earnings Guidance for the Second Quarter of 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 21.69x | 6.8x | 0.89x | 4.47x | 9.65x | 17.87x | 2.23% | 638M | ||
| 30.86x | 3.94x | 1.76x | 6.82x | 15.1x | 15.4x | -.--% | 32.06B | ||
| 89.26x | 50.06x | 0.92x | 76.5x | 95.28x | 98.85x | 0.41% | 14.18B | ||
| 82.04x | 20.7x | 5.08x | 12.1x | 52.53x | 60.79x | 0.71% | 5.58B | ||
| -32.6x | 8.39x | 0.44x | 9.16x | -49.62x | -42.98x | - | 2.24B | ||
| 60.26x | - | 0.03x | - | - | - | -.--% | 2.14B | ||
| -5.97x | - | 0.11x | 59.09x | -5.99x | -5.55x | - | 1.75B | ||
| -118.75x | - | 42.75x | - | - | - | - | 1.11B | ||
| 6.46x | - | -0.01x | - | - | - | - | 936M | ||
| 118.67x | 1.39x | -1.06x | - | - | - | 1.12% | 814M | ||
| -74.4x | 96.36x | 8.58x | 965.49x | -90.13x | -78.36x | -.--% | 736M | ||
| 2438.14x | - | -23.98x | - | - | - | -.--% | 679M | ||
| -7.78x | 1.79x | 0.09x | 0.6x | 11.85x | 17.22x | 1.86% | 638M | ||
| -15.31x | - | 0.17x | -0.38x | -2.76x | -6.51x | -.--% | 534M | ||
| -6.42x | - | 0.29x | - | - | - | - | 489M | ||
| -31.78x | 2.11x | 0.47x | - | - | - | - | 381M | ||
| 43.4x | - | -0.38x | - | - | - | - | 369M | ||
| 34.66x | - | 0.32x | 2.55x | 9.7x | 10.23x | - | 326M | ||
| Average | 146.25x | 21.28x | 2.02x | 113.64x | 4.56x | 8.69x | 0.63% | 3.64B | |
| Weighted average by Cap. | 66.19x | 18.31x | 2.08x | 37.64x | 33.32x | 35.67x | 0.23% |
- Stock Market
- Stocks
- RAY B Stock
- Sector RaySearch Laboratories AB
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















